UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Supercharged chimeric antigen receptor T cells in solid tumors

The Journal of clinical investigation, 2022-08, Vol.132 (16), p.1-3

2022

Volltextzugriff (PDF)

Alternative Checkpoints as Targets for Immunotherapy

Current oncology reports, 2020-12, Vol.22 (12), p.126-126, Article 126

2020

Volltextzugriff (PDF)

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Cancer gene therapy, 2020-09, Vol.27 (9), p.669-679

2020

Volltextzugriff (PDF)

Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes

Proceedings of the National Academy of Sciences - PNAS, 2023-09, Vol.120 (38), p.e2312277120-e2312277120

2023

Volltextzugriff (PDF)

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1956142-1956142

2021

Volltextzugriff (PDF)

CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy

Oncoimmunology, 2024, Vol.13 (1), p.2338965-2338965

2024

Volltextzugriff (PDF)

Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1940673-1940673

2021

Volltextzugriff (PDF)

Checkpoint blockade in recurrent meningiomas: Lessons for future management

Neuro-oncology (Charlottesville, Va.), 2022-01, Vol.24 (1), p.114-115

2022

Volltextzugriff (PDF)

Understanding innate immune response in glioblastoma in search of a way forward

Neuro-oncology (Charlottesville, Va.), 2020-04, Vol.22 (4), p.444-445

2020

Volltextzugriff (PDF)

Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors

Advances in experimental medicine and biology, 2023, Vol.1394, p.73-84

2023

Volltextzugriff (PDF)

Advances in co-opting anti-depressant drugs in glioma therapy

Cell reports. Medicine, 2022-12, Vol.3 (12), p.100837-100837, Article 100837

2022

Volltextzugriff (PDF)

Dewarping Documents Using C2 Continuous Boundary Estimation

ICASSP 2023 - 2023 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), 2023, p.1-5

2023

Volltextzugriff (PDF)

347 Cancer-associated Fibroblasts Affect GBM Progression

Neurosurgery, 2022-04, Vol.68 (Supplement_1), p.81-81

2022

Volltextzugriff (PDF)

346 Cancer-associated Fibroblasts in Glioblastoma Mouse Model Impact the Lymphoid Cells in the Tumor Microenvironment

Neurosurgery, 2022-04, Vol.68 (Supplement_1), p.81-81

2022

Volltextzugriff (PDF)

IMMU-13. EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii107-ii107

2020

Volltextzugriff (PDF)

456 CD39 T Cells With Low PD-1 Expression are Markers for Durable Immunotherapy Response to Anti-PD-1 in Murine Glioblastoma

Neurosurgery, 2023-04, Vol.69 (Supplement_1), p.94-94

2023

Volltextzugriff (PDF)

1241 Sustained Localized Delivery of Anti-PD-1 to Tumor Draining Lymph Nodes Increases Survival and Reverses Immunosuppression in Murine Glioblastoma Models

Neurosurgery, 2024-04, Vol.70 (Supplement_1), p.195-195

2024

Volltextzugriff (PDF)

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization

Nature cell biology, 2018-09, Vol.20 (9), p.1084-1097

2018

Volltextzugriff (PDF)

SYST-32 A NOVEL APPROACH TO TARGET TREG-MEDIATED IMMUNOSUPPRESSION IN GBM

Neuro-oncology advances, 2023-08, Vol.5 (Supplement_3), p.iii34-iii34

2023

Volltextzugriff (PDF)

The safety and efficacy of dexamethasone in the perioperative management of glioma patients

Journal of neurosurgery, 2022-04, Vol.136 (4), p.1062-1069

2022

Volltextzugriff (PDF)

159 PD-1 Agonism as a Strategy to Prevent Neuroinflammation After Acute Large Vessel Occlusion

Neurosurgery, 2024-04, Vol.70 (Supplement_1), p.37-37

2024

Volltextzugriff (PDF)

Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma

Journal of neurosurgery, 2022-02, Vol.136 (2), p.379-388

2022

Volltextzugriff (PDF)

Glutamate Modulation Synergizes With Anti-PD-1 Immunotherapy in Glioblastoma

Neurosurgery, 2020-12, Vol.67 (Supplement_1)

2020

Volltextzugriff (PDF)

PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage

Neurosurgery, 2021-04, Vol.88 (4), p.855-863

2021

Volltextzugriff (PDF)

The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function

Immunity (Cambridge, Mass.), 2024-08, Vol.57 (8), p.1864-1877.e9

2024

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Supercharged chimeric antigen receptor T cells in solid tumors

Alternative Checkpoints as Targets for Immunotherapy

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genes

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy

Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma

Checkpoint blockade in recurrent meningiomas: Lessons for future management

Understanding innate immune response in glioblastoma in search of a way forward

Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors

Advances in co-opting anti-depressant drugs in glioma therapy

Dewarping Documents Using C2 Continuous Boundary Estimation

347 Cancer-associated Fibroblasts Affect GBM Progression

346 Cancer-associated Fibroblasts in Glioblastoma Mouse Model Impact the Lymphoid Cells in the Tumor Microenvironment

IMMU-13. EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

456 CD39 T Cells With Low PD-1 Expression are Markers for Durable Immunotherapy Response to Anti-PD-1 in Murine Glioblastoma

1241 Sustained Localized Delivery of Anti-PD-1 to Tumor Draining Lymph Nodes Increases Survival and Reverses Immunosuppression in Murine Glioblastoma Models

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization

SYST-32 A NOVEL APPROACH TO TARGET TREG-MEDIATED IMMUNOSUPPRESSION IN GBM

The safety and efficacy of dexamethasone in the perioperative management of glioma patients

159 PD-1 Agonism as a Strategy to Prevent Neuroinflammation After Acute Large Vessel Occlusion

Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma

Glutamate Modulation Synergizes With Anti-PD-1 Immunotherapy in Glioblastoma

PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage

The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function

Suchergebnisse filtern